Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics

Hanno Ehlken; Christoph Schramm

doi:10.1159/000347206

Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics

Standard

Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics. / Ehlken, Hanno ; Schramm, Christoph.

in: DIGEST DIS, Jahrgang 31, Nr. 1, 01.01.2013, S. 118-25.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Ehlken, H & Schramm, C 2013, 'Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics', DIGEST DIS, Jg. 31, Nr. 1, S. 118-25. https://doi.org/10.1159/000347206

APA

Ehlken, H., & Schramm, C. (2013). Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics. DIGEST DIS, 31(1), 118-25. https://doi.org/10.1159/000347206

Vancouver

Ehlken H , Schramm C. Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics. DIGEST DIS. 2013 Jan 1;31(1):118-25. https://doi.org/10.1159/000347206

Bibtex

@article{70303a41bafa4481844af1cea11cbca8,

title = "Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics",

abstract = "Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease caused by progressive inflammation of the intra- and extrahepatic bile duct system. PSC patients have an increased risk to develop hepatobiliary as well as extrahepatic malignancies. The goal of a surveillance strategy for hepatobiliary malignancy in these patients is the detection of early cancer which will allow a potentially curative therapy. Here, we focus on a conceptual review of the pathogenesis of cholangiocellular carcinoma and gallbladder cancer and we will discuss a rational approach for the surveillance of these malignancies in PSC patients.",

keywords = "Bile Duct Neoplasms, Bile Ducts, Intrahepatic, Cholangiocarcinoma, Cholangitis, Sclerosing, Diagnostic Techniques, Digestive System, Gallbladder Neoplasms, Humans",

author = "Hanno Ehlken and Christoph Schramm",

note = "Copyright {\textcopyright} 2013 S. Karger AG, Basel.",

year = "2013",

month = jan,

day = "1",

doi = "10.1159/000347206",

language = "English",

volume = "31",

pages = "118--25",

journal = "DIGEST DIS",

issn = "0257-2753",

publisher = "S. Karger AG",

number = "1",

}

RIS

TY - JOUR

T1 - Primary sclerosing cholangitis and cholangiocarcinoma: pathogenesis and modes of diagnostics

AU - Ehlken, Hanno

AU - Schramm, Christoph

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease caused by progressive inflammation of the intra- and extrahepatic bile duct system. PSC patients have an increased risk to develop hepatobiliary as well as extrahepatic malignancies. The goal of a surveillance strategy for hepatobiliary malignancy in these patients is the detection of early cancer which will allow a potentially curative therapy. Here, we focus on a conceptual review of the pathogenesis of cholangiocellular carcinoma and gallbladder cancer and we will discuss a rational approach for the surveillance of these malignancies in PSC patients.

AB - Primary sclerosing cholangitis (PSC) is a chronic cholestatic liver disease caused by progressive inflammation of the intra- and extrahepatic bile duct system. PSC patients have an increased risk to develop hepatobiliary as well as extrahepatic malignancies. The goal of a surveillance strategy for hepatobiliary malignancy in these patients is the detection of early cancer which will allow a potentially curative therapy. Here, we focus on a conceptual review of the pathogenesis of cholangiocellular carcinoma and gallbladder cancer and we will discuss a rational approach for the surveillance of these malignancies in PSC patients.

KW - Bile Duct Neoplasms

KW - Bile Ducts, Intrahepatic

KW - Cholangiocarcinoma

KW - Cholangitis, Sclerosing

KW - Diagnostic Techniques, Digestive System

KW - Gallbladder Neoplasms

KW - Humans

U2 - 10.1159/000347206

DO - 10.1159/000347206

M3 - SCORING: Journal article

C2 - 23797133

VL - 31

SP - 118

EP - 125

JO - DIGEST DIS

JF - DIGEST DIS

SN - 0257-2753

IS - 1

ER -